The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Molecular Mechanisms of Treatment Resistance in Glioblastoma
Open accessAbstract
Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. Despite our growing understanding of the various mechanisms underlying treatment failure, the standard-of-care therapy has not changed over the last two decades, signifying a great unmet need. The challenges of treating glioblastoma are many and include inadequate drug or agent delivery across the blood–brain barrier, abundant intra- and intertumoral heterogeneity, redundant signaling pathways, and an immunosuppressive microenvironment. Here, we review the innate and adaptive molecular mechanisms underlying glioblastoma’s treatment resistance, emphasizing the intrinsic challenges therapeutic interventions must overcome—namely, the blood–brain barrier, tumoral heterogeneity, and microenvironment—and the mechanisms of resistance to conventional treatments, targeted therapy, and immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, J., Cheng, P., Pavlyukov, M. S., Yu, H., Zhang, Z., Kim, S.-H., Minata, M., Mohyeldin, A., Xie, W., Chen, D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89092 · Cited by 96
RetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationDaneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Neftel, C., Laffy, J., Filbin, M. G., Hara, T., Shore, M. E., Rahme, G. J., Richman, A. R., Silverbush, D., Shaw, M. L., Hebert, C. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.024 · Cited by 2,873
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308345 · Cited by 2,557
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,189
Self-citationWang, Q., Hu, B., Hu, X., Kim, H., Squatrito, M., Scarpace, L., deCarvalho, A. C., Lyu, S., Li, P., Li, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.003 · Cited by 1,995
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Brown, C. E., Alizadeh, D., Starr, R., Weng, L., Wagner, J. R., Naranjo, A., Ostberg, J. R., Blanchard, M. S., Kilpatrick, J., Simpson, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610497 · Cited by 1,836
O’Rourke, D. M., Nasrallah, M. P., Desai, A., Melenhorst, J. J., Mansfield, K., Morrissette, J. J. D., Martinez-Lage, M., Brem, S., Maloney, E., Shen, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0984 · Cited by 1,803
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., Garren, N., Mackey, M., Butman, J. A., Camphausen, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3055 · Cited by 1,577
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Peng, W., Chen, J. Q., Liu, C., Malu, S., Creasy, C., Tetzlaff, M. T., Xu, C., McKenzie, J. A., Zhang, C., Liang, X., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0283 · Cited by 1,539
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Keskin, D. B., Anandappa, A. J., Sun, J., Tirosh, I., Mathewson, N. D., Li, S., Oliveira, G., Giobbie-Hurder, A., Felt, K., Gjini, E., et al. (2019) · Nature · doi:10.1038/s41586-018-0792-9 · Cited by 1,432
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Stupp, R., Taillibert, S., Kanner, A. A., Kesari, S., Steinberg, D. M., Toms, S. A., Taylor, L. P., Lieberman, F., Silvani, A., Fink, K. L., et al. (2015) · JAMA · doi:10.1001/jama.2015.16669 · Cited by 1,259
Jacob, F., Salinas, R. D., Zhang, D. Y., Nguyen, P. T. T., Schnoll, J. G., Wong, S. Z. H., Thokala, R., Sheikh, S., Saxena, D., Prokop, S., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.036 · Cited by 1,149
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., & Schuler, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1303 · Cited by 1,139
Weller, M., Butowski, N., Tran, D. D., Recht, L. D., Lim, M., Hirte, H., Ashby, L., Mechtler, L., Goldlust, S. A., Iwamoto, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30517-x · Cited by 1,134
Klemm, F., Maas, R. R., Bowman, R. L., Kornete, M., Soukup, K., Nassiri, S., Brouland, J.-P., Iacobuzio-Donahue, C. A., Brennan, C., Tabar, V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.007 · Cited by 1,037
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031
Darmanis, S., Sloan, S. A., Croote, D., Mignardi, M., Chernikova, S., Samghababi, P., Zhang, Y., Neff, N., Kowarsky, M., Caneda, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.030 · Cited by 997
Pappenheimer, J. R., Renkin, E. M., & Borrero, L. M. (1951) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1951.167.1.13 · Cited by 977
Balancing repair and tolerance of DNA damage caused by alkylating agents
Fu, D., Calvo, J. A., & Samson, L. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3185 · Cited by 947
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J. K., Fang, X., Sloan, A. E., Mao, Y., Lathia, J. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.021 · Cited by 905
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Zhao, J., Chen, A. X., Gartrell, R. D., Silverman, A. M., Aparicio, L., Chu, T., Bordbar, D., Shan, D., Samanamud, J., Mahajan, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0349-y · Cited by 903
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.010 · Cited by 850
The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
Alvarez, J. I., Dodelet-Devillers, A., Kebir, H., Ifergan, I., Fabre, P. J., Terouz, S., Sabbagh, M., Wosik, K., Bourbonnière, L., Bernard, M., et al. (2011) · Science · doi:10.1126/science.1206936 · Cited by 845
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Desjardins, A., Gromeier, M., Herndon, J. E., Beaubier, N., Bolognesi, D. P., Friedman, A. H., Friedman, H. S., McSherry, F., Muscat, A. M., Nair, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716435 · Cited by 815
Patnaik, A., Rosen, L. S., Tolaney, S. M., Tolcher, A. W., Goldman, J. W., Gandhi, L., Papadopoulos, K. P., Beeram, M., Rasco, D. W., Hilton, J. F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0095 · Cited by 743
Clonal evolution of glioblastoma under therapy
Wang, J., Cazzato, E., Ladewig, E., Frattini, V., Rosenbloom, D. I. S., Zairis, S., Abate, F., Liu, Z., Elliott, O., Shin, Y.-J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3590 · Cited by 720
Lang, F. F., Conrad, C., Gomez-Manzano, C., Yung, W. K. A., Sawaya, R., Weinberg, J. S., Prabhu, S. S., Rao, G., Fuller, G. N., Aldape, K. D., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.8219 · Cited by 711
Self-citationGlioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Friebel, E., Kapolou, K., Unger, S., Núñez, N. G., Utz, S., Rushing, E. J., Regli, L., Weller, M., Greter, M., Tugues, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.055 · Cited by 685
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Chongsathidkiet, P., Jackson, C., Koyama, S., Loebel, F., Cui, X., Farber, S. H., Woroniecka, K., Elsamadicy, A. A., Dechant, C. A., Kemeny, H. R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0135-2 · Cited by 668
Notch Promotes Radioresistance of Glioma Stem Cells
Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B., Wang, X.-F., White, R. R., Rich, J. N., & Sullenger, B. A. (2010) · Stem Cells · doi:10.1002/stem.261 · Cited by 656
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Woroniecka, K., Chongsathidkiet, P., Rhodin, K., Kemeny, H., Dechant, C., Farber, S. H., Elsamadicy, A. A., Cui, X., Koyama, S., Jackson, C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1846 · Cited by 654
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Schalper, K. A., Rodriguez-Ruiz, M. E., Diez-Valle, R., López-Janeiro, A., Porciuncula, A., Idoate, M. A., Inogés, S., de Andrea, C., López-Diaz de Cerio, A., Tejada, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0339-5 · Cited by 642
Fecci, P. E., Mitchell, D. A., Whitesides, J. F., Xie, W., Friedman, A. H., Archer, G. E., Herndon, J. E., Bigner, D. D., Dranoff, G., & Sampson, J. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3773 · Cited by 617
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Ichimura, K., Pearson, D. M., Kocialkowski, S., Bäcklund, L. M., Chan, R., Jones, D. T. W., & Collins, V. P. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-025 · Cited by 595
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1
Hussain, S. F., Yang, D., Suki, D., Aldape, K., Grimm, E., & Heimberger, A. B. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-008 · Cited by 592
Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.011 · Cited by 583
Longitudinal molecular trajectories of diffuse glioma in adults
Barthel, F. P., Johnson, K. C., Varn, F. S., Moskalik, A. D., Tanner, G., Kocakavuk, E., Anderson, K. J., Abiola, O., Aldape, K., Alfaro, K. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1775-1 · Cited by 561
Self-citationImmune microenvironment of gliomas
Gieryng, A., Pszczolkowska, D., Walentynowicz, K. A., Rajan, W. D., & Kaminska, B. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.19 · Cited by 538
Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D’Andre, S. D., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1507-6 · Cited by 537
Roos, W. P., Batista, L. F. Z., Naumann, S. C., Wick, W., Weller, M., Menck, C. F. M., & Kaina, B. (2007) · Oncogene · doi:10.1038/sj.onc.1209785 · Cited by 495
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
Giles, A. J., Hutchinson, M.-K. N. D., Sonnemann, H. M., Jung, J., Fecci, P. E., Ratnam, N. M., Zhang, W., Song, H., Bailey, R., Davis, D., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0371-5 · Cited by 492
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
Kunwar, S., Chang, S., Westphal, M., Vogelbaum, M., Sampson, J., Barnett, G., Shaffrey, M., Ram, Z., Piepmeier, J., Prados, M., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop054 · Cited by 483
Cahill, D. P., Levine, K. K., Betensky, R. A., Codd, P. J., Romany, C. A., Reavie, L. B., Batchelor, T. T., Futreal, P. A., Stratton, M. R., Curry, W. T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2149 · Cited by 452
Glioblastoma targeted therapy: updated approaches from recent biological insights
Touat, M., Idbaih, A., Sanson, M., & Ligon, K. L. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx106 · Cited by 441
Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq142 · Cited by 433
Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A., & Zou, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6730 · Cited by 416
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 414
The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein
Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V., & Riordan, J. R. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80136-x · Cited by 411
Kim, H., Zheng, S., Amini, S. S., Virk, S. M., Mikkelsen, T., Brat, D. J., Grimsby, J., Sougnez, C., Muller, F., Hu, J., et al. (2015) · Genome Research · doi:10.1101/gr.180612.114 · Cited by 411
Hodges, T. R., Ott, M., Xiu, J., Gatalica, Z., Swensen, J., Zhou, S., Huse, J. T., de Groot, J., Li, S., Overwijk, W. W., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox026 · Cited by 404
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Kitange, G. J., Carlson, B. L., Schroeder, M. A., Grogan, P. T., Lamont, J. D., Decker, P. A., Wu, W., James, C. D., & Sarkaria, J. N. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-090 · Cited by 390
Tukachinsky, H., Lopez, L. V., & Salic, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004108 · Cited by 389
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Meyer, M., Reimand, J., Lan, X., Head, R., Zhu, X., Kushida, M., Bayani, J., Pressey, J. C., Lionel, A. C., Clarke, I. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320611111 · Cited by 382
Camisaschi, C., Casati, C., Rini, F., Perego, M., De Filippo, A., Triebel, F., Parmiani, G., Belli, F., Rivoltini, L., & Castelli, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903879 · Cited by 350
Reardon, D. A., Omuro, A., Brandes, A. A., Rieger, J., Wick, A., Sepulveda, J., Phuphanich, S., de Souza, P., Ahluwalia, M. S., Lim, M., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox036.071 · Cited by 325
Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
Mellinghoff, I. K., Ellingson, B. M., Touat, M., Maher, E., De La Fuente, M. I., Holdhoff, M., Cote, G. M., Burris, H., Janku, F., Young, R. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03327 · Cited by 324
Akkari, L., Bowman, R. L., Tessier, J., Klemm, F., Handgraaf, S. M., de Groot, M., Quail, D. F., Tillard, L., Gadiot, J., Huse, J. T., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7843 · Cited by 320
Michaud, K., Solomon, D. A., Oermann, E., Kim, J.-S., Zhong, W.-Z., Prados, M. D., Ozawa, T., James, C. D., & Waldman, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4559 · Cited by 319
Spatiotemporal Evolution of the Primary Glioblastoma Genome
Kim, J., Lee, I.-H., Cho, H. J., Park, C.-K., Jung, Y.-S., Kim, Y., Nam, S. H., Kim, B. S., Johnson, M. D., Kong, D.-S., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.013 · Cited by 314
Hussain, S. F., Kong, L.-Y., Jordan, J., Conrad, C., Madden, T., Fokt, I., Priebe, W., & Heimberger, A. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1243 · Cited by 314
Andaloussi, A. E., & Lesniak, M. S. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-006 · Cited by 311
Lu, C., Wei, Y., Wang, X., Zhang, Z., Yin, J., Li, W., Chen, L., Lyu, X., Shi, Z., Yan, W., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1137-5 · Cited by 303
Gill, B. J., Pisapia, D. J., Malone, H. R., Goldstein, H., Lei, L., Sonabend, A., Yun, J., Samanamud, J., Sims, J. S., Banu, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405839111 · Cited by 297
Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
Mathios, D., Kim, J. E., Mangraviti, A., Phallen, J., Park, C.-K., Jackson, C. M., Garzon-Muvdi, T., Kim, E., Theodros, D., Polanczyk, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2942 · Cited by 296
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
Di Stefano, A. L., Fucci, A., Frattini, V., Labussiere, M., Mokhtari, K., Zoppoli, P., Marie, Y., Bruno, A., Boisselier, B., Giry, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2199 · Cited by 293
Wang, W., Dentler, W. L., & Borchardt, R. T. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.1.h434 · Cited by 288
Wen, P. Y., Reardon, D. A., Armstrong, T. S., Phuphanich, S., Aiken, R. D., Landolfi, J. C., Curry, W. T., Zhu, J.-J., Glantz, M., Peereboom, D. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0261 · Cited by 287
Isocitrate dehydrogenase mutations in gliomas
Waitkus, M. S., Diplas, B. H., & Yan, H. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov136 · Cited by 282
P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells
Tsuji, A., Terasaki, T., Takabatake, Y., Tenda, Y., Tamai, I., Yamashima, T., Moritani, S., Tsuruo, T., & Yamashita, J. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90537-y · Cited by 282
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
Wang, Q., He, Z., Huang, M., Liu, T., Wang, Y., Xu, H., Duan, H., Ma, P., Zhang, L., Zamvil, S. S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03050-0 · Cited by 277
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
Li, Y., Li, A., Glas, M., Lal, B., Ying, M., Sang, Y., Xia, S., Trageser, D., Guerrero-Cázares, H., Eberhart, C. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016912108 · Cited by 266
Griveau, A., Seano, G., Shelton, S. J., Kupp, R., Jahangiri, A., Obernier, K., Krishnan, S., Lindberg, O. R., Yuen, T. J., Tien, A.-C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.020 · Cited by 261
Guryanova, O. A., Wu, Q., Cheng, L., Lathia, J. D., Huang, Z., Yang, J., MacSwords, J., Eyler, C. E., McLendon, R. E., Heddleston, J. M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.004 · Cited by 260
Körber, V., Yang, J., Barah, P., Wu, Y., Stichel, D., Gu, Z., Fletcher, M. N. C., Jones, D., Hentschel, B., Lamszus, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.007 · Cited by 260
Gpr124 is essential for blood–brain barrier integrity in central nervous system disease
Chang, J., Mancuso, M. R., Maier, C., Liang, X., Yuki, K., Yang, L., Kwong, J. W., Wang, J., Rao, V., Vallon, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4309 · Cited by 255
Zhou, W., Chen, C., Shi, Y., Wu, Q., Gimple, R. C., Fang, X., Huang, Z., Zhai, K., Ke, S. Q., Ping, Y.-F., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.10.002 · Cited by 231
Hossain, A., Gumin, J., Gao, F., Figueroa, J., Shinojima, N., Takezaki, T., Priebe, W., Villarreal, D., Kang, S.-G., Joyce, C., et al. (2015) · Stem Cells · doi:10.1002/stem.2053 · Cited by 224
Regulation and roles for claudin‐family tight junction proteins
Findley, M. K., & Koval, M. (2009) · IUBMB Life · doi:10.1002/iub.175 · Cited by 224
Brown, M. C., Holl, E. K., Boczkowski, D., Dobrikova, E., Mosaheb, M., Chandramohan, V., Bigner, D. D., Gromeier, M., & Nair, S. K. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4220 · Cited by 224
Lechner, M. G., Megiel, C., Russell, S. M., Bingham, B., Arger, N., Woo, T., & Epstein, A. L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-90 · Cited by 209
Characterization of PDZ-binding kinase, a mitotic kinase
Gaudet, S., Branton, D., & Lue, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090102397 · Cited by 208
Uhm, J. H., Ballman, K. V., Wu, W., Giannini, C., Krauss, J. C., Buckner, J. C., James, C. D., Scheithauer, B. W., Behrens, R. J., Flynn, P. J., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.01.070 · Cited by 192
Alvarado, A. G., Thiagarajan, P. S., Mulkearns-Hubert, E. E., Silver, D. J., Hale, J. S., Alban, T. J., Turaga, S. M., Jarrar, A., Reizes, O., Longworth, M. S., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.12.001 · Cited by 187
Zhai, L., Ladomersky, E., Lauing, K. L., Wu, M., Genet, M., Gritsina, G., Győrffy, B., Brastianos, P. K., Binder, D. C., Sosman, J. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0120 · Cited by 177
EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner
Kim, S.-H., Joshi, K., Ezhilarasan, R., Myers, T. R., Siu, J., Gu, C., Nakano-Okuno, M., Taylor, D., Minata, M., Sulman, E. P., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.12.006 · Cited by 175
Rampling, R., Peoples, S., Mulholland, P. J., James, A., Al-Salihi, O., Twelves, C. J., McBain, C., Jefferies, S., Jackson, A., Stewart, W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0506 · Cited by 172
Ma, D. J., Galanis, E., Anderson, S. K., Schiff, D., Kaufmann, T. J., Peller, P. J., Giannini, C., Brown, P. D., Uhm, J. H., McGraw, S., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou328 · Cited by 171
Crane, C. A., Ahn, B. J., Han, S. J., & Parsa, A. T. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos014 · Cited by 169
Park, M.-J., Lee, S., Kim, E., Lee, E., Baek, J.-A., Park, S., Kwok, S., & Cho, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21856-2 · Cited by 165
Wnt activation is implicated in glioblastoma radioresistance
Kim, Y., Kim, K., Lee, J., Lee, Y.-A., Kim, M., Lee, S. J., Park, K., Yang, H., Jin, J., Joo, K., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2011.161 · Cited by 161
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Lassman, A. B., Pugh, S. L., Gilbert, M. R., Aldape, K., Geinoz, S., Beumer, J. H., Christner, S. M., Komaki, R. U., DeAngelis, L. M., Gaur, R., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov011 · Cited by 157
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Shi, Y., Guryanova, O. A., Zhou, W., Liu, C., Huang, Z., Fang, X., Wang, X., Chen, C., Wu, Q., He, Z., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6816 · Cited by 154
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors
Schreck, K. C., Grossman, S. A., & Pratilas, C. A. (2019) · Cancers · doi:10.3390/cancers11091262 · Cited by 150
Xia, S., Lal, B., Tung, B., Wang, S., Goodwin, C. R., & Laterra, J. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov171 · Cited by 147
Huang, M., Zhang, D., Wu, J. Y., Xing, K., Yeo, E., Li, C., Zhang, L., Holland, E. C., Yao, L., Qin, L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay7522 · Cited by 143
Wu, A., Maxwell, R., Xia, Y., Cardarelli, P. M., Oyasu, M., Belcaid, Z., Kim, E. S., Hung, A. L., Luksik, A. S., Garzón-Muvdi, T., et al. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03172-5 · Cited by 142
Hardcastle, J. J., Mills, L., Malo, C. S., Jin, F., Kurokawa, C., Geekiyanage, H., Schroeder, M. A., Sarkaria, J. N., Johnson, A. J., & Galanis, E. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now179 · Cited by 141
PTEN methylation and expression in glioblastomas
Baeza, N., Weller, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0748-4 · Cited by 139
SINGLE CELL DERIVED CLONAL ANALYSIS OF HUMAN GLIOBLASTOMA LINKS FUNCTIONAL AND GENOMIC HETEROGENEITY
Dirks, P. B., Meyer, M., Reimand, J., Lan, X., Head, R., Zhu, X., Kushida, M. M., Bayani, J., Pressey, J. C., Lionel, A. C., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.51 · Cited by 133
Zeng, A.-L., Yan, W., Liu, Y.-W., Wang, Z., Hu, Q., Nie, E., Xin Min, Z. H. O. U., Li, R., Wang, X.-F., Jiang, T., et al. (2017) · Oncogene · doi:10.1038/onc.2017.134 · Cited by 129
Huang, M., Liu, T., Ma, P., Mitteer, R. A., Zhang, Z., Kim, H. J., Yeo, E., Zhang, D., Cai, P., Li, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84876 · Cited by 128
Targeting the c-Met Pathway Potentiates Glioblastoma Responses to γ-Radiation
Lal, B., Xia, S., Abounader, R., & Laterra, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0166 · Cited by 120
Immunotherapy in CNS cancers: the role of immune cell trafficking
Ratnam, N. M., Gilbert, M. R., & Giles, A. J. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy084 · Cited by 119
Chen, Q., Han, B. R., Meng, X., Duan, C., Yang, C., Wu, Z., Dinislam, M., Zhao, S., Safin, S. M., Jiang, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32102 · Cited by 116
Verreault, M., Schmitt, C., Goldwirt, L., Pelton, K., Haidar, S., Levasseur, C., Guehennec, J., Knoff, D., Labussière, M., Marie, Y., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1015 · Cited by 114
Hypoxic glioblastoma release exosomal VEGF-A induce the permeability of blood-brain barrier
Zhao, C., Wang, H., Xiong, C., & Liu, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.140 · Cited by 112
Valdor, R., García‐Bernal, D., Riquelme, D., Martínez, C. M., Moraleda, J. M., Cuervo, A. M., Macián, F., & Martínez, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903542116 · Cited by 112
Chi, A. S., Batchelor, T. T., Kwak, E. L., Clark, J. W., Wang, D. L., Wilner, K. D., Louis, D. N., & Iafrate, A. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4586 · Cited by 110
Peereboom, D. M., Ahluwalia, M. S., Ye, X., Supko, J. G., Hilderbrand, S. L., Phuphanich, S., Nabors, B., Rosenfeld, M. R., Mikkelsen, T., & Grossman, S. A. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos322 · Cited by 109
Radiation-Induced Centrosome Overduplication and Multiple Mitotic Spindles in Human Tumor Cells
Sato, N., Mizumoto, K., Nakamura, M., & Tanaka, M. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4797 · Cited by 105
STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma
Lau, J., Ilkhanizadeh, S., Wang, S., Miroshnikova, Y. A., Salvatierra, N. A., Wong, R. A., Schmidt, C., Weaver, V. M., Weiss, W. A., & Persson, A. I. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3331 · Cited by 101
Tien, A., Li, J., Bao, X., Derogatis, A., Kim, S., Mehta, S. V., & Sanai, N. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0133 · Cited by 100
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis
Kim, Y. W., Koul, D., Kim, S. H., Lucio-Eterovic, A. K., Freire, P. R., Yao, J. C., Wang, J., Almeida, J. S., Aldape, K., & Yung, W. K. A. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not024 · Cited by 98
Self-citationChen, K., Lin, Y.-J., Chai, W., Lin, C.-J., Chen, P., Huang, C.-Y., Kuo, J. S., Liu, H.-L., & Wei, K. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-344 · Cited by 97
Lassen, U., Mau‐Sørensen, M., Gaziel, T. B. B., Hasselbalch, B., & Poulsen, H. S. (2013) · PubMed · Cited by 96
Lim, Y. C., Roberts, T. L., Day, B. W., Harding, A. S., Kozlov, S., Kijas, A. W., Ensbey, K. S., Walker, D., & Lavin, M. F. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-1044 · Cited by 95
Valdor, R., García‐Bernal, D., Bueno, C., Rodenas, M., Moraleda, J. M., Macián, F., & Martínez, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19804 · Cited by 94
Huang, K., Liu, X., Li, Y., Wang, Q., Zhou, J., Wang, Y., Dong, F., Yang, C., Sun, Z., Fang, C., et al. (2019) · Advanced Science · doi:10.1002/advs.201900782 · Cited by 91
Hu, B., Nandhu, M. S., Sim, H., Agudelo-Garcia, P. A., Saldivar, J. C., Dolan, C. E., Mora, M. E., Nuovo, G. J., Cole, S. E., & Viapiano, M. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1060 · Cited by 90
Kizilbash, S. H., Gupta, S. K., Chang, K., Kawashima, R., Parrish, K. E., Carlson, B. L., Bakken, K. K., Mladek, A. C., Schroeder, M. A., Decker, P. A., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0365 · Cited by 90
Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma
Luoto, S., Hermelo, I., Vuorinen, E. M., Hannus, P., Kesseli, J., Nykter, M., & Granberg, K. J. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3714 · Cited by 89
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Schäfer, N., Gielen, G. H., Rauschenbach, L., Kebir, S., Till, A., Reinartz, R., Simon, M., Niehusmann, P., Kleinschnitz, C., Herrlinger, U., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1846-y · Cited by 83
Chang, K., Hsu, T., Hsu, C.-C., Tsai, S.-Y., Liu, J.-J., Chou, S.-W., Liu, M.-S., Liou, J., Ko, C., Chen, K., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.005 · Cited by 82
van den Bossche, W. B. L., Kleijn, A., Teunissen, C. E., Voerman, J. S. A., Teodósio, C., Noske, D. P., van Dongen, J. J. M., Dirven, C. M. F., & Lamfers, M. L. M. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy082 · Cited by 82
Shinsato, Y., Furukawa, T., Yunoue, S., Yonezawa, H., Minami, K., Nishizawa, Y., Ikeda, R., Kawahara, K., Yamamoto, M., Hirano, H., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1302 · Cited by 81
Bah, I., Kumbhare, A., Nguyen, L. N., McCall, C. E., & Gazzar, M. E. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.003 · Cited by 80
Pandey, V., Haider, T., Chandak, A., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.326 · Cited by 80
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor
Costa, B., Bendinelli, S., Gabelloni, P., Da Pozzo, E., Daniele, S., Scatena, F., Vanacore, R., Campiglia, P., Bertamino, A., Gomez-Monterrey, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072281 · Cited by 79
Genetic and Functional Diversity of Propagating Cells in Glioblastoma
Piccirillo, S. G. M., Colman, S., Potter, N. E., van Delft, F. W., Lillis, S., Carnicer, M.-J., Kearney, L., Watts, C., & Greaves, M. F. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.11.003 · Cited by 78
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma
Fianco, G., Mongiardi, M. P., Levi, A., Luca, T. D., Desideri, M., Trisciuoglio, D., Bufalo, D. D., Cinà, I., Benedetto, A. D., Mottolese, M., et al. (2017) · eLife · doi:10.7554/elife.22593 · Cited by 78
Inhibition of NF-κB Signaling Ablates the Invasive Phenotype of Glioblastoma
Westhoff, M., Zhou, S., Nonnenmacher, L., Karpel‐Massler, G., Jennewein, C., Schneider, M. B., Halatsch, M., Carragher, N. O., Baumann, B., Krause, A., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0435-t · Cited by 75
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Skaga, E., Kulesskiy, E., Fayzullin, A., Sandberg, C. J., Potdar, S., Kyttälä, A., Langmoen, I. A., Laakso, A., Gaál‐Paavola, E., Perola, M., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5861-4 · Cited by 75
Hottinger, A. F., Aïssa, A. B., Espeli, V. G., Squiban, D., Dunkel, N., Vargas, M. I., Hundsberger, T., Mach, N., Schaller, K., Weber, D., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.209 · Cited by 72
Kast, R. E., Hill, Q. A., Wion, D., Mellstedt, H., Focosi, D., Karpel‐Massler, G., Heiland, T., & Halatsch, M. (2017) · Tumor Biology · doi:10.1177/1010428317699797 · Cited by 70
Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells
Wang, Y., Xu, H., Liu, T., Huang, M., Butter, P.-P., Li, C., Zhang, L., Kao, G. D., Gong, Y., Maity, A. M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98096 · Cited by 65
Tu, Y., Chen, Z., Zhao, P., Sun, G., Bao, Z., Chao, H., Fan, L., Li, C., You, Y., Qu, Y., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1515 · Cited by 65
Herting, C. J., Chen, Z., Pitter, K. L., Szulzewsky, F., Kaffes, I., Kaluzová, M., Park, J. C., Cimino, P. J., Brennan, C., Wang, B., et al. (2017) · Glia · doi:10.1002/glia.23203 · Cited by 64
Kim, E. L., Sorokin, M., Kantelhardt, S. R., Kalasauskas, D., Sprang, B., Fauß, J., Ringel, F. A., Garazha, A., Albert, E. A., Гайфуллин, Н., et al. (2020) · Cancers · doi:10.3390/cancers12020520 · Cited by 64
Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4+ T cells
Hahn, S. A., Stahl, H. F., Becker, C., Correll, A., Schneider, F.-J., Tuettenberg, A., & Jonuleit, H. (2013) · Blood · doi:10.1182/blood-2012-12-474478 · Cited by 62
Pesenti, C., Navone, S. E., Guarnaccia, L., Terrasi, A., Costanza, J., Silipigni, R., Guarneri, S., Fusco, N., Fontana, L., Locatelli, M., et al. (2019) · Stem Cells International · doi:10.1155/2019/2617030 · Cited by 60
Roudnicky, F., Kim, B. K., Lan, Y., Schmucki, R., Küppers, V., Christensen, K., Graf, M. R., Patsch, C., Burcin, M. M., Meyer, C. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60688-x · Cited by 58
Akgül, S., Patch, A.-M., D’Souza, R. C. J., Mukhopadhyay, P., Nones, K., Kempe, S., Kazakoff, S. H., Jeffree, R. L., Stringer, B. W., Pearson, J. V., et al. (2019) · Cancers · doi:10.3390/cancers11020190 · Cited by 57
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
Hiddingh, L., Tannous, B. A., Teng, J., Tops, B. B. J., Jeuken, J. W. M., Hulleman, E., Boots‐Sprenger, S., Vandertop, W. P., Noske, D. P., Kaspers, G. J. L., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1620 · Cited by 55
Comba, A., Dunn, P., Argento, A. E., Kadiyala, P., Ventosa, M., Patel, P., Zamler, D. B., Núñez, F. J., Zhao, L., Castro, M. G., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa006 · Cited by 51
Miyazaki, T., Ishikawa, E., Matsuda, M., Sugii, N., Kohzuki, H., Akutsu, H., Sakamoto, N., Takano, S., & Matsumura, A. (2020) · Brain Tumor Pathology · doi:10.1007/s10014-020-00357-z · Cited by 47
EZH2 Phosphorylation Promotes Self-Renewal of Glioma Stem-Like Cells Through NF-κB Methylation
Liu, H., Sun, Y., Qi, X., Gordon, R. E., O'Brien, J. A., Yuan, H., Zhang, J., Wang, Z., Zhang, M., Song, Y., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00641 · Cited by 45
Klingler, S., Guo, B., Yao, J., Yan, H., Zhang, L., Vaseva, A. V., Chen, S., Canoll, P., Horner, J. W., Wang, Y., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3122 · Cited by 43
Nguyen, L. V., Searle, K., & Jerzak, K. J. (2019) · Oncotarget · doi:10.18632/oncotarget.27238 · Cited by 41
Nandhu, M. S., Kwiatkowska, A., Bhaskaran, V., Hayes, J. L., Hu, B., & Viapiano, M. S. (2017) · Oncogene · doi:10.1038/onc.2017.109 · Cited by 40
Kim, G. W., Lee, D. H., Yeon, S.-K., Jeon, Y. H., Yoo, J. H., Lee, S. W., & Kwon, S. H. (2019) · Anticancer Research · doi:10.21873/anticanres.13888 · Cited by 40
Becker, C. M., Oberoi, R. K., McFarren, S. J., Muldoon, D. M., Pafundi, D., Pokorny, J. L., Brinkmann, D. H., Ohlfest, J. R., Sarkaria, J. N., Largaespada, D. A., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov081 · Cited by 39
Replication protein A and more: single-stranded DNA-binding proteins in eukaryotic cells
Liu, T., & Huang, J. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw041 · Cited by 39
Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation
Cheng, Y., & Shieh, S.-Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719856115 · Cited by 39
Jeon, H.-Y., Ham, S. W., Kim, J.-K., Jin, X. J., Lee, S. Y., Shin, Y. J., Choi, C., Sa, J. K., Kim, S. H., Chun, T., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0282-0 · Cited by 39
Replication Protein A (RPA) Mediates Radio-Resistance of Glioblastoma Cancer Stem-Like Cells
Pedersen, H., Obara, E. A. A., Elbæk, K. J., Vitting‐Seerup, K., & Hamerlik, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051588 · Cited by 38
Heiland, D. H., Gaebelein, A., Börries, M., Wörner, J., Pompe, N., Franco, P., Heynckes, S., Bartholomae, M., hAilín, D. Ó., Carro, M. S., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0680 · Cited by 37
Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma
Stark, A. M., Doukas, A., Hugo, H. ‐., Hedderich, J., Hattermann, K., Mehdorn, H. M., & Held‐Feindt, J. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000409 · Cited by 32
Akiyama, Y., Nonomura, C., Ashizawa, T., Iizuka, A., Kondou, R., Miyata, H., Sugino, T., Mitsuya, K., Hayashi, N., Nakasu, Y., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.005 · Cited by 32
GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme
Zimmer, N., Kim, E. L., Schupp, J., Sprang, B., Leukel, P., Khafaji, F., Ringel, F. A., Sommer, C., Tuettenberg, J., & Tuettenberg, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153676 · Cited by 30
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts
Carbone, D., Sharpnack, M. F., He, K., Butterfield, L. H., Eggermont, A. M. M., González‐Cao, M., Karachaliou, N., Crespo, G., Aldeguer, E., Drozdowskyj, A., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-017-1352-z · Cited by 28
Mettang, M., Meyer-Pannwitt, V., Karpel‐Massler, G., Zhou, S., Carragher, N. O., Föhr, K. J., Baumann, B., Nonnenmacher, L., Enzenmüller, S., Dahlhaus, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23592-z · Cited by 28
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients
Dutoit, V., Philippin, G., Widmer, V., Marinari, E., Vuilleumier, A., Migliorini, D., Schaller, K., & Dietrich, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00089 · Cited by 25
Multiple Subsets of Brain Tumor Initiating Cells Coexist in Glioblastoma
Rennert, R. C., Achrol, A. S., Januszyk, M., Kahn, S. A., Liu, T. T., Liu, Y., Sahoo, D., Rodrigues, M., Maan, Z. N., Wong, V., et al. (2016) · Stem Cells · doi:10.1002/stem.2359 · Cited by 20
Yamashiro, K., Nakao, K., Ohba, S., & Hirose, Y. (2020) · Anticancer Research · doi:10.21873/anticanres.14073 · Cited by 18
Cited by
Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer
Avgoulas, D. I., Tasioulis, K. S., Papi, R. M., & Pantazaki, A. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051439 · Cited by 57
MDM2/X inhibitors as radiosensitizers for glioblastoma targeted therapy
Miles, X., Vandevoorde, C., Hunter, A., & Bolcaen, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.703442 · Cited by 40
Targeting ACAT1 in cancer: from threat to treatment
Sun, T., & Xiao, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1395192 · Cited by 31
Metadata
- Authors
- Ou, A., Yung, W. K. A., & Majd, N.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-12-31
- Volume
- 22
- Issue
- 1
- Pages
- 351
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3114996910
- Cited by
- 269
- References
- 196
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.